Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06345703
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-03-19
Brief Title:
First-into-human Study of NS-136 in Healthy Subjects
Sponsor:
NeuShen Therapeutics
Organization:
NeuShen Therapeutics
Study Overview
Official Title:
A Phase 1 Double-blind Placebo-controlled Study to Evaluate the Safety Tolerability and PK of Single and Multiple Ascending Oral Doses and Food Effect of NS-136 in Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to exlplore the profile of NS-136 in health conditions The main questions it aims to answer are
Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen
What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing regimen
Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen
What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing regimen
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None